Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Preparation of 13-epi-selamectin by biotransformation using a blocked mutant of Streptomyces avermitilis.

The Journal of antibiotics - 1 Mar 2000

Pacey M S, Dutton C J, Monday R A, Ruddock J C, Smith G C

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biotransformation
Share to Insecticides
Share to Magnetic Resonance Spectroscopy
Share to Mutation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Siphonaptera

Share to Streptomyces

Source

Identifiers

PMID: 10819303
DOI: 10.7164/antibiotics.53.301

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Preparation of 13-epi-selamectin by biotransformation using a blocked mutant of Streptomyces avermitilis.PMID 10819303Read ↗

Control of avermectin biosynthesis in Streptomyces avermitilis for the selective production of a useful component.Semantic proximity Read ↗

Production of 6,8a-seco-6,8a-deoxy derivatives of avermectins by a mutant strain of Streptomyces avermitilis.Semantic proximity Read ↗

1,19-seco-Avermectin analogues from a ΔaveCDE mutant Streptomyces avermectinius strain.Semantic proximity Read ↗

New Avermectin Analogues from a Mutant Streptomyces avermectinius Strain.Semantic proximity Read ↗

Enhancement and selective production of avermectin B by recombinants of Streptomyces avermitilis via intraspecific protoplast fusionSemantic proximity Read ↗

Direct production of ivermectin-like drugs after domain exchange in the avermectin polyketide synthase of Streptomyces avermitilis ATCC31272.Semantic proximity Read ↗

Production of the antitumor drug epirubicin (4'-epidoxorubicin) and its precursor by a genetically engineered strain of Streptomyces peucetius.Semantic proximity Read ↗

Biosynthetic studies on oleandomycin by incorporation of the chemically synthesized aglycones.Semantic proximity Read ↗

Two new aromatic tenvermectins from mutant Streptomyces avermitilis HU02-06.Semantic proximity Read ↗

Production of the staurosporine aglycon K-252c with a blocked mutant of the staurosporine producer strain Streptomyces longisporoflavus and by biotransformation of staurosporine with Streptomyces mediocidicus ATCC 13279.Semantic proximity Read ↗

Novel avermectins produced by mutational biosynthesis.Semantic proximity Read ↗

3'-Demethoxy-3'-hydroxystaurosporine, a novel staurosporine analogue produced by a blocked mutant.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.